Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Meera Narasimhan, Chi Un Pae, Natasha Masand & Prakash Masand. (2007) Partial compliance with antipsychotics and its impact on patient outcomes. International Journal of Psychiatry in Clinical Practice 11:2, pages 102-111.
Read now
Read now
Robert M Post. (2005) Adjunctive strategies in the treatment of refractory bipolar depression: clinician options in the absence of a systematic database. Expert Opinion on Pharmacotherapy 6:4, pages 531-546.
Read now
Read now
Articles from other publishers (18)
Rachel E. Hardy, Injae Chung, Yizhou Yu, Samantha H. Y. Loh, Nobuhiro Morone, Clement Soleilhavoup, Marco Travaglio, Riccardo Serreli, Lia Panman, Kelvin Cain, Judy Hirst, Luis M. Martins, Marion MacFarlane & Kenneth R. Pryde. (2023) The antipsychotic medications aripiprazole, brexpiprazole and cariprazine are off-target respiratory chain complex I inhibitors. Biology Direct 18:1.
Crossref
Crossref
Pierre-Michel Llorca, Philippe Nuss, Éric Fakra, Isabelle Alamome, Dominique Drapier, Wissam El Hage, Renaud Jardri, Stéphane Mouchabac, Marc Rabbani, Nicolas Simon, Marie-Noëlle Vacheron & Jean-Michel Azorin. (2022) Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study. BMC Psychiatry 22:1.
Crossref
Crossref
Alessio Alesci, Simona Pergolizzi, Patrizia Lo Cascio, Angelo Fumia & Eugenia Rita Lauriano. (2021) Neuronal regeneration: Vertebrates comparative overview and new perspectives for neurodegenerative diseases. Acta Zoologica 103:2, pages 129-140.
Crossref
Crossref
Radomir Juza, Iveta Vojtechova, Kristyna Stefkova-Mazochova, Wim Dehaen, Tomas Petrasek, Lukas Prchal, Tereza Kobrlova, Jiri Janousek, Premysl Vlcek, Eva Mezeiova, Daniel Svozil, Jana Zdarova Karasova, Jaroslav Pejchal, Holger Stark, Grzegorz Satala, Andrzej J. Bojarski, Monika Kubacka, Szczepan Mogilski, Alena Randakova, Kamil Musilek, Ondrej Soukup & Jan Korabecny. (2022) Novel D2/5-HT receptor modulators related to cariprazine with potential implication to schizophrenia treatment. European Journal of Medicinal Chemistry 232, pages 114193.
Crossref
Crossref
Laila Asth, Lia P. Iglesias, Rayssa C. Briânis, Anna P. Marçal, Nícia P. Soares, Daniele C. Aguiar & Fabrício A. Moreira. (2021) Effects of the monoamine stabilizer, (-)-OSU6162, on cocaine-induced locomotion and conditioned place preference in mice. Naunyn-Schmiedeberg's Archives of Pharmacology 394:6, pages 1143-1152.
Crossref
Crossref
Yavor Danov, Dilyana Georgieva, Rositsa Mihaylova, Bistra Kostova & Petar D. Petrov. (2021) Cryogel Carriers Comprising β‐Cyclodextrin Moieties for Improved Solubilization and Delivery of Aripiprazole. Macromolecular Chemistry and Physics 222:7, pages 2100004.
Crossref
Crossref
Deborah Galvão Coelho da Silva, Luiz Kae Sales Kanazawa & Débora Dalla Vecchia. (2019) Schizophrenia: effects of aripiprazole in metabolic syndrome. Brazilian Journal of Pharmaceutical Sciences 55.
Crossref
Crossref
Ferdinando Garetto, Ferdinando Cancelli, Romina Rossi & Marco Maltoni. (2018) Palliative Sedation for the Terminally Ill Patient. CNS Drugs 32:10, pages 951-961.
Crossref
Crossref
Leila Moezi, Mahsa Hosseini, Simin Oveisi, Hossein Niknahad & Hamed Shafaroodi. (2015) The Effects of Sub-Chronic Treatment with Aripiprazole on Pentylenetetrazole- and Electroshock-Induced Seizures in Mice: The Role of Nitric Oxide. Pharmacology 95:5-6, pages 264-270.
Crossref
Crossref
Anja Cerovecki, Richard Musil, Ansgar Klimke, Florian Seemüller, Ekkehard Haen, Rebecca Schennach, Kai-Uwe Kühn, Hans-Peter Volz & Michael Riedel. (2013) Withdrawal Symptoms and Rebound Syndromes Associated with Switching and Discontinuing Atypical Antipsychotics: Theoretical Background and Practical Recommendations. CNS Drugs 27:7, pages 545-572.
Crossref
Crossref
David Taylor, Carol Paton & Shitij Kapur. 2009. The Maudsley Prescribing Guidelines, Tenth Edition. The Maudsley Prescribing Guidelines, Tenth Edition
9
122
.
Jerzy Kossakowski, Anna Bielenica, Marta Struga & Anna E. Koziol. (2008) Synthesis and pharmacological evaluation of 4-[2-hydroxy-3-(4-phenyl-piperazin-1-yl)-propoxy]-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione. Medicinal Chemistry Research 17:8, pages 507-514.
Crossref
Crossref
Z. Nourian, T. Mow, D. Muftic, S. Burek, M. L. Pedersen, J. Matz & M. J. Mulvany. (2008) Orthostatic hypotensive effect of antipsychotic drugs in Wistar rats by in vivo and in vitro studies of α1-adrenoceptor function. Psychopharmacology 199:1, pages 15-27.
Crossref
Crossref
Michael J. Marino, Lars J. S. Knutsen & Michael Williams. (2008) Emerging Opportunities for Antipsychotic Drug Discovery in the Postgenomic Era. Journal of Medicinal Chemistry 51:5, pages 1077-1107.
Crossref
Crossref
M. Brandt-Christensen, M. B. Andersen, A. Fink-Jensen, T. Werge & J. Gerlach. (2005) The substituted (S)-3-phenylpiperidine (−)-OSU6162 reduces apomorphine- and amphetamine-induced behaviour in Cebus apella monkeys. Journal of Neural Transmission 113:1, pages 11-19.
Crossref
Crossref
Thomas A. Rugino & Yvette M. Janvier. (2016) Aripiprazole in Children and Adolescents: Clinical Experience. Journal of Child Neurology 20:7, pages 603-610.
Crossref
Crossref
Paz Toren, Sharon Ratner, Nathaniel Laor & Abraham Weizman. (2004) Benefit-Risk Assessment of Atypical Antipsychotics in the Treatment of Schizophrenia and Comorbid Disorders in Children and Adolescents. Drug Safety 27:14, pages 1135-1156.
Crossref
Crossref
Jud A Staller. (2016) Aripiprazole in an Adult with Asperger Disorder. Annals of Pharmacotherapy 37:11, pages 1628-1631.
Crossref
Crossref